Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
346.61
-6.99 (-1.98%)
4:49:38 PM EDT: $347.94 +1.33 (+0.38%)
Products

U.S. FDA Says Revisions To Patient And Provider Fact Sheets For Moderna, Pfizer-Biontech COVID-19 Vaccines On Increased Risks Of Myocarditis,Pericarditis

Published: 06/26/2021 00:05 GMT
Moderna Inc (MRNA) - Revisions to Patient and Provider Fact Sheets for Moderna, Pfizer-biontech Covid-19 Vaccines on Increased Risks of Myocarditis,pericarditis.
For Each Vaccine, Fact Sheet for Vaccination Providers Has Been Revised to Include Warning About Myocarditis and Pericarditis.
For Each Vaccine, Fact Sheet Fact Sheet for Recipients and Caregivers Has Been Revised to Include Information About Myocarditis and Pericarditis.
The Update Follows an Extensive Review of Information and Discussion by Cdc's Advisory Committee on Immunization Practices Meeting on Wednesday.
Warning in Fact Sheets Notes Reports of Adverse Events Suggest Increased Risks of Myocarditis and Pericarditis, Particularly Following Second Dose.
Fact Sheets for Recipients, Caregivers Note That They Should Seek Medical Attention Right Away If They Have Symptoms Including Chest Pain.
Further Company Coverage: [22uay.
De].
((reuters.
Briefs@thomsonreuters.
Com;)).